Journal Article

Network pharmacology and experimental verification study on the mechanism of Hedyotis diffusa Willd in treating colorectal cancer

Li, Yaoxuan, Huang, Haifu, Yuan, Xiya, Tang, Zhenhao, Yu, Changhui

2024

Overview

This study aimed to evaluate the pharmacological mechanism of Hedyotis diffusa Willd against CRC (colorectal cancer) using network pharmacological analysis combined with experimental validation. The active components and potential targets of Hedyotis diffusa Willd were screened from the tax compliance management program public database using network pharmacology. The core anti-CRC targets were screened using a protein-protein interaction (PPI) network. The mRNA and protein expression of core target genes in normal colon and CRC tissues and their relationship with overall CRC survival were evaluated using The Cancer Genome Atlas (TCGA), Human Protein Atlas (HPA), and Gene Expression Profiling Interactive Analysis (GEPIA) databases. Functional and pathway enrichment analyses of the potential targets were performed using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). The first six core targets with stable binding were molecular-docked with the active components quercetin and β-sitosterol. Finally, the results of network pharmacology were verified using in vitro experiments. In total, 149 potential targets were identified by searching for seven types of active components and the intersection of all potential and CRC targets. PPI network analysis showed that ten target genes, including tumor protein p53 (TP53) and recombinant cyclin D1 (CCND1), were pivotal genes. GO enrichment analysis involved 2043 biological processes, 52 cellular components, and 191 molecular functions. KEGG enrichment analysis indicated that the anticancer effects of H. alba were mediated by tumor necrosis factor, interleukin-17, and nuclear factor-κB (NF-κB) signaling pathways. Validation of key targets showed that the validation results for most core genes were consistent with those in this study. Molecular docking revealed that the ten core target proteins could be well combined with quercetin and β-sitosterol and the structure remained stable after binding. The results of the in vitro experiment showed that β-sitosterol inhibited proliferation and induced apoptosis in SW620 cells. This study identified a potential target plant for CRC through network pharmacology and in vitro validation.

• Publisher: Springer Berlin Heidelberg,Springer Nature B.V
• Subject: Antineoplastic Agents, Phytogenic - pharmacology / Apoptosis / Apoptosis - drug effects / Biomedical and Life Sciences / Biomedicine / Cell Line, Tumor / Cell proliferation / Cell Proliferation - drug effects / Colon cancer / Colorectal cancer / Colorectal Neoplasms - drug therapy / Colorectal Neoplasms - genetics / Colorectal Neoplasms - metabolism / Colorectal Neoplasms - pathology / Cyclin D1 / Gene expression / Gene Expression Regulation, Neoplastic - drug effects / Genes / Hedyotis - chemistry / Hedyotis diffusa / Humans / Interleukin 17 / Molecular Docking Simulation / Network Pharmacology / Neurosciences / NF-κB protein / p53 Protein / Pharmacology / Pharmacology/Toxicology / Plant cells / Plant Extracts - pharmacology / Plant Extracts - therapeutic use / Protein interaction / Protein Interaction Maps / Proteins / Quercetin / Quercetin - pharmacology / Sitosterols - pharmacology